Suppr超能文献

门诊临终关怀中抗生素处方的决定因素:一项区域观察性研究

Determinants of Antibiotic Prescription in Outpatient Hospice: A Regional Observational Study.

作者信息

Crowley Patrick D, Whalen Francis X, Siegel Leslie R, Challener Douglas W

机构信息

Division of Public Health, Infectious Disease, and Occupational Medicine, Mayo Clinic, Rochester, MN, USA.

Department of Anesthesiology, and Palliative and Supportive Care, Mayo Clinic, Rochester, MN, USA.

出版信息

Am J Hosp Palliat Care. 2025 Feb 2:10499091251317662. doi: 10.1177/10499091251317662.

Abstract

BACKGROUND

Patients enrolling in hospice care are asked their preferences for antibiotic treatment. There is little information regarding which patients are more likely to receive antibiotics. To better inform discussions, we sought to characterize the use of antibiotics in the outpatient hospice setting.

METHODS

We performed a retrospective review of patients enrolled in outpatient hospice within the Mayo Clinic Health System from 1/1/2017 through 1/1/2023. We calculated what percent of patients received antibiotics based on Hospice Qualifying Condition (HQC), age at enrollment, sex, survival time, and Charlson Comorbidity Index and calculated adjusted odds ratios (aOR). We documented which antibiotics were prescribed based on HQC.

RESULTS

Of 6452 patients identified, 1259 (19.5%) received antibiotic prescriptions. Cephalosporins were the most common class of antibiotics prescribed (22.8% of antibiotics prescribed), followed by fluoroquinolones (20.3%) and penicillin derivatives (14.9%). Patients with Pulmonary HQCs were most likely to receive antibiotics (28.6% aOR 1.85 [1.51-2.25]), those with neurologic HQCs were least likely (14.9% aOR 0.66 [0.53-0.83]). There was no difference of age for those receiving antibiotics (80.7 yr) vs those not receiving (80.3 yr [ = 0.25]), or for sex (male vs female aOR 1.10 [0.96-1.26). 4.6% of those surviving <7d received antibiotics (aOR .22 [0.17-0.29]), compared to 47.7% of those surviving >6mo (aOR 4.46 [3.50-5.69]).

DISCUSSION

19.5% of patients will receive antibiotics during their hospice course, with more frequent prescriptions in those surviving longer periods and those enrolled for pulmonary conditions. It is important to clarify patient preferences regarding antimicrobial utilization at the time of hospice enrollment.

摘要

背景

临终关怀机构会询问患者对抗生素治疗的偏好。关于哪些患者更有可能接受抗生素治疗的信息很少。为了更好地为相关讨论提供依据,我们试图描述门诊临终关怀环境中抗生素的使用情况。

方法

我们对2017年1月1日至2023年1月1日在梅奥诊所医疗系统登记的门诊临终关怀患者进行了回顾性研究。我们根据临终关怀资格条件(HQC)、入组时年龄、性别、生存时间和Charlson合并症指数计算接受抗生素治疗的患者百分比,并计算调整后的优势比(aOR)。我们记录了根据HQC开具的抗生素种类。

结果

在6452名确定的患者中,1259名(19.5%)接受了抗生素处方。头孢菌素是最常用的抗生素类别(占抗生素处方的22.8%),其次是氟喹诺酮类(20.3%)和青霉素衍生物(14.9%)。患有肺部HQC的患者最有可能接受抗生素治疗(28.6%,aOR 1.85 [1.51 - 2.25]),患有神经系统HQC的患者可能性最小(14.9%,aOR 0.66 [0.53 - 0.83])。接受抗生素治疗的患者(80.7岁)与未接受治疗的患者(80.3岁,P = 0.25)在年龄上没有差异,性别方面也无差异(男性与女性,aOR 1.10 [0.96 - 1.26])。存活时间<7天的患者中有4.6%接受了抗生素治疗(aOR 0.22 [0.17 - 0.29]),而存活时间>6个月的患者中有47.7%接受了抗生素治疗(aOR 4.46 [3.50 - 5.69])。

讨论

19.5%的患者在临终关怀期间会接受抗生素治疗,存活时间较长的患者和因肺部疾病入组的患者开具抗生素处方的频率更高。在临终关怀登记时明确患者对抗菌药物使用的偏好很重要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验